SATB1 and neoplasm: Additionally, upon in vivo pulsing Satb1-silenced tumour-associated DCs with the full-length ovalbumin (OVA), CD3+CFSE+OT-I+ T cells in situ responded to the cognate antigen in the ovarian cancer microenvironment stronger than those tumour-associated DCs in control mice treated with irrelevant nanoparticles.